This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Neonatal cholestasis is a condition that affects newborn babies, caused by a blockage of bile flow from the liver to the intestines. It is characterized by itching skin, yellowish staining of the skin and whites of the eyes, and dark urine. In most cases, the condition will resolve itself and the baby will not suffer long-term effects. However, if left untreated, neonatal cholestasis can result in serious liver damage, jaundice, malnutrition, and even death. Neonatal cholestasis is most often caused by a genetic disorder, such as alpha-1 antitrypsin deficiency, Dubin-Johnson syndrome, or a bile acid synthesis defect. These genetic disorders can be inherited, or can occur spontaneously in the baby due to a mutation in the genes. In some cases, the cause of the condition can also be due to an infection, a medication taken by the mother during pregnancy, or a complication of another condition such as cystic fibrosis. Diagnosis of neonatal cholestasis is usually done through a combination of blood tests and imaging studies. The blood tests measure the levels of bile acids in the blood, which are elevated in cases of neonatal cholestasis. Imaging studies, such as ultrasound or magnetic resonance imaging (MRI), can help to identify any obstruction of the bile ducts. Treatment of neonatal cholestasis is typically done with medication to help relieve the symptoms and prevent further damage to the liver. These medications include ursodeoxycholic acid, which helps to reduce bile acid levels and reduce the itching, as well as vitamin K supplementation to help prevent bleeding. If the cause of the condition is an infection, antibiotics may be prescribed. Surgery may be necessary if the blockage is due to a physical obstruction of the bile duct. Neonatal cholestasis is a serious condition that can have long-term implications, including liver damage and malnutrition. It is important to diagnose and treat the condition early to help prevent long-term complications. It is also important for parents to seek out genetic counseling if the condition is hereditary.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States